LIPELLA PHARMACEUTICALS INC. (LIPO) SEC Filings & Financial Intelligence
LIPELLA PHARMACEUTICALS INC. (LIPO) is a publicly traded company, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LIPO
CIK: 1347242
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Urish Popeck & Company, LLC
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerDavid Ritzert
Audit LocationPittsburgh, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-07-15 | 2026-06-12 | FORM 8-K | 0001753926-26-001173 | View SEC Doc Filr Page |
| 8-K | 2026-03-31 | 2026-03-30 | FORM 8-K | 0001753926-26-000577 | View SEC Doc Filr Page |
| 8-K | 2026-02-04 | 2026-02-03 | 8-K | 0001753926-26-000265 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | FORM 10Q | 0001753926-25-001805 | View SEC Doc Filr Page |
| 8-K | 2025-10-21 | 2025-10-20 | 8-K | 0001753926-25-001636 | View SEC Doc Filr Page |
| 8-K | 2025-10-09 | 2025-10-03 | 8-K | 0001753926-25-001602 | View SEC Doc Filr Page |
| 25-NSE | 2025-10-06 | — | 25-NSE Filing | 0001354457-25-000985 | View SEC Doc Filr Page |
| 8-K | 2025-09-18 | 2025-09-18 | 8-K | 0001753926-25-001525 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | 10-Q | 0001753926-25-001347 | View SEC Doc Filr Page |
| 8-K | 2025-06-25 | 2025-06-25 | 8-K | 0001753926-25-001003 | View SEC Doc Filr Page |
| 8-K | 2025-06-20 | 2025-06-20 | FORM 8-K | 0001753926-25-000984 | View SEC Doc Filr Page |
| 8-K | 2025-06-16 | 2025-06-16 | 8-K | 0001753926-25-000962 | View SEC Doc Filr Page |
| PRE 14A | 2025-06-10 | 2025-07-21 | PRE 14A | 0001753926-25-000952 | View SEC Doc Filr Page |
| 8-K | 2025-05-16 | 2025-05-16 | 8-K | 0001753926-25-000856 | View SEC Doc Filr Page |
| 8-K | 2025-05-15 | 2025-05-15 | 8-K | 0001753926-25-000842 | View SEC Doc Filr Page |
| 10-Q | 2025-05-14 | 2025-03-31 | 10-Q | 0001753926-25-000818 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-05-01 | — | SCHEDULE 13G/A Filing | 0001753926-25-000727 | View SEC Doc Filr Page |
| 8-K | 2025-04-14 | 2025-04-14 | 8-K | 0001753926-25-000623 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-04-09 | — | SCHEDULE 13D/A Filing | 0001753926-25-000614 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-04-09 | — | SCHEDULE 13D/A Filing | 0001753926-25-000612 | View SEC Doc Filr Page |
| 8-K | 2025-04-09 | 2025-04-09 | 8-K | 0001753926-25-000604 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-04-07 | — | SCHEDULE 13D/A Filing | 0001753926-25-000592 | View SEC Doc Filr Page |
| 4 | 2025-04-07 | 2025-04-03 | 4 Filing | 0001753926-25-000590 | View SEC Doc Filr Page |
| 8-K | 2025-04-07 | 2025-04-07 | 8-K | 0001753926-25-000585 | View SEC Doc Filr Page |
| 424B5 | 2025-04-04 | — | 424B5 | 0001753926-25-000582 | View SEC Doc Filr Page |